Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

HIF-1α Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target

Blood (2016) 128 (22): 305.

https://doi.org/10.1182/blood.V128.22.305.305

Published: 2016

Journal Articles

A Comparative Study of Biosimilar Filgrastim Versus Originator G-CSF for CD34+ Cells Mobilization and Autografting in Hematological Malignancies

Lucia Brunello, Luisa Giaccone, Maria Josè Fornaro, Matilde Scaldaferri, Valter Redoglia, Paola Omedè, PhD, Moreno Festuccia, Giovannino Ciccone, Massimo Massaia, MD, Dario Ferrero, Federica Cavallo, Antonio Palumbo, MD, Francesco Cattel, Andrea Evangelista, Mario Boccadoro, MD, Benedetto Bruno, MD PhD

Blood (2016) 128 (22): 2183.

https://doi.org/10.1182/blood.V128.22.2183.2183

Published: 2016

Journal Articles

Flowcytometric Minimal Residual Disease Assessment in the EMN-02/HOVON-95 MM Trial: Used Methods and a Comparison of Their Sensitivity

Davine Hofste op Bruinink, MD MSc, Stefania Oliva, MD, Lucie Rihova, PhD, Bronno van der Holt, PhD, Milena Gilestro, BSc, Jeroen G. te Marvelde, BSc, Pavla Vsianska, MSc, Alexander Schmitz, PhD, Helle Høholt, BSc, Hans Erik Johnsen, MDDMSc, Mario Boccadoro, MD, Roman Hajek, MD, Pieter Sonneveld, MD PhD, Antonio Palumbo, MD, Paola Omedè, PhD, Vincent H.J. van der Velden, PhD

Blood (2016) 128 (22): 2072.

https://doi.org/10.1182/blood.V128.22.2072.2072

Published: 2016

Journal Articles

Prolonged Follow-up Confirmed a Role for Upfront Tandem Auto-Allo Transplant in Multiple Myeloma Also in the Era of New Drugs

Luisa Giaccone, Andrea Evangelista, Francesca Patriarca, Roberto Sorasio, MD, Massimo Pini, MD, Fabrizio Carnevale Schianca, MD, Moreno Festuccia, Lucia Brunello, Francesco Zallio, MD, Enrico Maffini, Paola Omedè, PhD, Sara Bringhen, MD, Nicola Mordini, MD, Renato Fanin, MD, Massimo Massaia, MD, Antonio Palumbo, MD, Giovannino Ciccone, MDPhD, Mario Boccadoro, MD, Benedetto Bruno, MD PhD

Blood (2016) 128 (22): 3469.

https://doi.org/10.1182/blood.V128.22.3469.3469

Published: 2016

Journal Articles

Circulating Mir-130a in Multiple Myeloma and Extramedullary Myeloma Patients

Lenka Kubiczkova-Besse, Lenka Sedlarikova, Fedor Kryukov, Lenka Radova, PhD, Jana Nekvindova, Pavel Nemec, Daniela Drandi, Simona Caltagirone, Paola Omedè, PhD, Marta Krejci, As Prof, MD PhD, Zdenek Adam, prof, MD PhD, Ludek Pour, Doc, MD PhD, Sabina Sevcikova, PhD, Antonio Palumbo, MD, Mario Boccadoro, Roman Hajek, Prof, MD PhD

Blood (2014) 124 (21): 2043.

https://doi.org/10.1182/blood.V124.21.2043.2043

Published: 2014

Journal Articles

Prospective Molecular Monitoring of Minimal Residual Disease after Non-Myeloablative Allografting in Newly Diagnosed Multiple Myeloma

Benedetto Bruno, MD PhD, Simone Ferrero, MD, Daniela Drandi, Moreno Festuccia, MD, Francesca Patriarca, MD, Nicola Mordini, MD, Silvia Cena, PhD, Daniela Barbero, PhD, Luigia Monitillo, PhD, Federica Ferrando, MD, Lucia Brunello, MD, Renato Fanin, MD, Paola Ghione, MD, Paola Omedè, PhD, Luisa Giaccone, MD PhD, Antonio Palumbo, MD, Roberto Passera, PhD, Mario Boccadoro, MD, Marco Ladetto, MD

Blood (2014) 124 (21): 44.

https://doi.org/10.1182/blood.V124.21.44.44

Published: 2014

Journal Articles

Multicolor Flowcytometry Analysis of Hematopoietic Stem and Progenitor Cells Subsets Among Basal and Mobilized Peripheral CD34+ Cells

Valentina Giai, MD, Elona Saraci, Eleonora Marzanati, Christian Scharenberg, MD, Monica De Stefanis, Paola Omedè, PhD, Eva Hellstrom-Lindberg, MD PhD, Antonio Palumbo, MD, Benedetto Bruno, MD PhD, Mario Boccadoro, MD, Dario Ferrero, MD PhD

Blood (2014) 124 (21): 5117.

https://doi.org/10.1182/blood.V124.21.5117.5117

Published: 2014

Journal Articles

Weekly Carfilzomib, Cyclophosphamide and Dexamethasone (wCCd) in Newly Diagnosed Multiple Myeloma Patients: A Phase I- II Study

Antonio Palumbo, MD, Davide Rossi, MD PhD, Sara Bringhen, MD, Alessandra Larocca, MD, Fabiana Gentilini, MDPhD, Lorenzo De Paoli, Paola Omedè, PhD, Stelvio Ballanti, MD, Federica Cavallo, MD, Roberto Passera, Anna Marina Liberati, MD, Mario Boccadoro, MD, Gianluca Gaidano, Pieter Sonneveld, MDPhD, Paolo Corradini, MD

Blood (2014) 124 (21): 175.

https://doi.org/10.1182/blood.V124.21.175.175

Published: 2014

Journal Articles

Cell-Free DNA for Minimal Residual Disease Monitoring in Multiple Myeloma Patients

Lenka Kubiczkova-Besse, Daniela Drandi, Lenka Sedlarikova, Stefania Oliva, MD, Manuela Gambella, Paola Omedè, PhD, Zdenek Adam, prof, MD PhD, Ludek Pour, Doc, MD PhD, Sabina Sevcikova, PhD, Mario Boccadoro, MD, Antonio Palumbo, MD, Roman Hajek, Prof, MD PhD

Blood (2014) 124 (21): 3423.

https://doi.org/10.1182/blood.V124.21.3423.3423

Published: 2014

Journal Articles

Minimal Residual Disease Monitoring During Maintenance In Multiple Myeloma Patients

Blood (2013) 122 (21): 3126.

https://doi.org/10.1182/blood.V122.21.3126.3126

Published: 2013

Journal Articles

A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients

Blood (2013) 122 (21): 687.

https://doi.org/10.1182/blood.V122.21.687.687

Published: 2013

NARROW

HIF-1α Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target

A Comparative Study of Biosimilar Filgrastim Versus Originator G-CSF for CD34+ Cells Mobilization and Autografting in Hematological Malignancies

Flowcytometric Minimal Residual Disease Assessment in the EMN-02/HOVON-95 MM Trial: Used Methods and a Comparison of Their Sensitivity

Extracellular Vesicles as Potential Biomarker for Acute Graft-Versus-Host-Disease

Prolonged Follow-up Confirmed a Role for Upfront Tandem Auto-Allo Transplant in Multiple Myeloma Also in the Era of New Drugs

Circulating Mir-130a in Multiple Myeloma and Extramedullary Myeloma Patients

Prospective Molecular Monitoring of Minimal Residual Disease after Non-Myeloablative Allografting in Newly Diagnosed Multiple Myeloma

Multicolor Flowcytometry Analysis of Hematopoietic Stem and Progenitor Cells Subsets Among Basal and Mobilized Peripheral CD34+ Cells

Weekly Carfilzomib, Cyclophosphamide and Dexamethasone (wCCd) in Newly Diagnosed Multiple Myeloma Patients: A Phase I- II Study

Cell-Free DNA for Minimal Residual Disease Monitoring in Multiple Myeloma Patients

Minimal Residual Disease Monitoring During Maintenance In Multiple Myeloma Patients

A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only